Ee-Chee Ren
Impact in
-
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Hepatitis C virus research
Papers in
-
- Ubiquitin and proteasome pathways 1
-
- Hepatitis B Virus Studies 2
- Co-authors
- Ziwei Xiao (2 shared papers)Bei Wang (2 shared papers)Rosa C. M. Y. Liang (3 shared papers)Keli Ou (3 shared papers)Teck Keong Seow (3 shared papers)Shao‐En Ong (3 shared papers)Lisa F. P. Ng (4 shared papers)Hui Ling Ko (1 shared paper)
- Journals
- Human Immunology (2 papers)BMC Infectious Diseases (2 papers)Journal of Medical Virology (2 papers)Electrophoresis (2 papers)Pediatric Nephrology (2 papers)
- Partner nations
- SingaporeUnited StatesVietnam
In The Last Decade
Ee-Chee Ren
19 papers receiving 602 citations
Peers
Comparison fields: 5 of 75
- Infectious Diseases 103
- Hepatology 41
- Oncology 105
- Molecular Biology 285
- Immunology 77
Countries citing papers authored by Ee-Chee Ren
This map shows the geographic impact of Ee-Chee Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ee-Chee Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ee-Chee Ren more than expected).
Fields of papers citing papers by Ee-Chee Ren
This network shows the impact of papers produced by Ee-Chee Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ee-Chee Ren. The network helps show where Ee-Chee Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Ee-Chee Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 123 | |
| 2 | 2010 | 75 | |
| 3 | 2004 | 71 | |
| 4 | 2008 | 54 | |
| 5 | 2005 | 48 | |
| 6 | 2004 | 39 | |
| 7 | 2006 | 36 | |
| 8 | 2001 | 33 | |
| 9 | 2011 | 30 | |
| 10 | 1999 | 26 | |
| 11 | 1990 | 21 | |
| 12 | 2009 | 18 | |
| 13 | 2015 | 13 | |
| 14 | 2002 | 10 | |
| 15 | 2000 | 8 | |
| 16 | 1999 | 6 | |
| 17 | 1995 | 4 | |
| 18 | 2005 | 4 | |
| 19 | 2000 | 4 |
About Ee-Chee Ren
Ee-Chee Ren is a scholar working on Molecular Biology, Epidemiology, Immunology, Infectious Diseases and Nephrology, having authored 19 papers that have together received 623 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Advanced Proteomics Techniques and Applications (2 papers), Hepatitis B Virus Studies (2 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Mass Spectrometry Techniques and Applications (2 papers), Renal Diseases and Glomerulopathies (2 papers) and Ubiquitin and proteasome pathways (1 paper). The work is most often cited by research in Infectious Diseases (103 citations), Hepatology (41 citations), Oncology (105 citations), Molecular Biology (285 citations) and Immunology (77 citations). Ee-Chee Ren has collaborated with scholars based in Singapore, United States and Vietnam. Frequent co-authors include Ziwei Xiao, Bei Wang, Rosa C. M. Y. Liang, Keli Ou, Teck Keong Seow, Shao‐En Ong, Lisa F. P. Ng, Hui Ling Ko, M.C.M. Chung and Lily Chan. Their work appears in journals such as Human Immunology, BMC Infectious Diseases, Journal of Medical Virology, Electrophoresis and Pediatric Nephrology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.